Biblio
“Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Similar Genetic Architecture of Alzheimer's Disease and Differential Effect Between Sexes.”, Front Aging Neurosci, vol. 13, p. 674318, 2021.
, “A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.”, Alzheimers Res Ther, vol. 11, no. 1, p. 71, 2019.
, “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.
, “A statistical framework for cross-tissue transcriptome-wide association analysis.”, Nat Genet, vol. 51, no. 3, pp. 568-576, 2019.
, “A survey of ABCA1 sequence variation confirms association with dementia.”, Hum Mutat, vol. 30, no. 9, pp. 1348-54, 2009.
, “A survey of genetic human cortical gene expression.”, Nat Genet, vol. 39, no. 12, pp. 1494-9, 2007.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “Transethnic genome-wide scan identifies novel Alzheimer's disease loci.”, Alzheimers Dement, vol. 13, no. 7, pp. 727-738, 2017.
, “TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.”, Mol Neurodegener, vol. 14, no. 1, p. 18, 2019.
, “Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.”, Alzheimers Dement, vol. 13, no. 2, pp. 119-129, 2017.
, “The ubiquilin 1 gene and Alzheimer's disease.”, N Engl J Med, vol. 352, no. 26, pp. 2752-3; author reply 2752-3, 2005.
, “Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.”, Ann Neurol, vol. 59, no. 1, pp. 21-6, 2006.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
, “Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.”, Am J Med Genet B Neuropsychiatr Genet, vol. 124B, no. 1, pp. 29-37, 2004.
, “Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.”, Neurology, vol. 43, no. 2, pp. 250-60, 1993.
, “Weighted burden analysis of exome-sequenced late-onset Alzheimer's cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3β and WNT signalling pathways.”, Ann Hum Genet, vol. 84, no. 3, pp. 291-302, 2020.
, “Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.”, Mol Psychiatry, 2018.
, “Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease.”, Ann Clin Transl Neurol, vol. 5, no. 4, pp. 406-417, 2018.
, “Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.”, Ann Clin Transl Neurol, vol. 5, no. 7, pp. 832-842, 2018.
,